AIRWAYS PHYSIOLOGY, PATHOPHYSIOLOGY & AIRWAYS DEFENSE

(380) Neutrophil Extracellular Traps Disrupt Bronchial Epithelial Barrier Function: Alpha-1 Antitrypsin to the Rescue

(381) Carbonic Anhydrase12 Knockout Mimics CF Cellular Phenotypes

(382) Mechanisms of Cysteine-Mediated Polymerization and Secretion of Muc5ac and Muc5b

(383) ELD607 Inhibits Excessive Proinflammatory Ca²⁺ Signaling in CF Neutrophils

(384) Impact of elexacaftor/tezacaftor/ivacaftor therapy on the pathological reprogramming of lung-recruited neutrophils conditioned by cystic fibrosis airway fluid

(385) Mechanisms by which CFTR may influence SARS-CoV-2 infection

(386) Myeloperoxidase activity and methionine oxidation products in bronchoalveolar lavage are associated with heightened risk of bronchiectasis in CF infants and toddlers

(387) Pre-infection Knockdown of Muc5b Reduces Severity of Chronic Pseudomonas aeruginosa Infection in the CFTR-KO Rat

(388) Rapid Viscoelastic Characterization of Airway Mucus Using a Benchtop Rheometer

(389) The toxicology of ELD607, a novel immunomodulator of inflammatory responses in CF lungs

(390) Proof-of-concept of ionocytes’ CFTR content as a novel biomarker for cystic fibrosis

(391) Lef-1 Induces FoxI1-Dependent Ionocyte Specification From Submucosal Gland Progenitors

(393) Consequences of Chronic Hyperglycemia in Human Cystic Fibrosis Bronchial Epithelial Barrier Function

(394) Development of a Programmable Automated Cell Culture System to Mimic Cystic Fibrosis-Related Diabetes Conditions In Vitro

(395) Absence of Slc26a9 function results in neonatal mortality in mice due to pulmonary complications.

(396) Lung Extracellular Matrix Remodeling in Human Cystic Fibrosis and Implications for Innate Immunity

(397) Sinonasal epithelial functional and transcriptional responses to long-term highly effective CFTR corrector therapy

(398) The role of carbonic anhydrase in pathogen susceptibility in cystic fibrosis

(401) Neutrophil Elastase Increases Intracellular Calpain Activity and Calcium in CF and non-CF Macrophages

(402) Inhibiting the neurogenic component of the response to hypertonic saline treatment increases mucociliary clearance in CF swine

(404) Why are mucins so gigantic and is it rational to sever them to aid mucus clearance?

(405) Neutrophil Defect and Pathogen Selection in Cystic Fibrosis

(406) Pulmonary ionocytes play a role in pH regulation in human airway epithelia

(407) MUC-031 as novel mucolytic agent for the treatment of cystic fibrosis

(408) Neutrophil Extracellular Traps (NETs) Must Spread and Overlap to Adversely Affect Mucus Rheology.

(410) Hypoxia-induced CFTR dysfunction is a universal mechanism underlying reduced mucociliary transport in sinusitis

(411) Insulin-like growth factor binding protein (IGFBP-6) as a novel regulator of inflammatory response in Cystic Fibrosis airway cells

(412) Novel Approaches to Identifying Ion Transport Dysfunction During the Nasal Potential Difference Assay

(413) Patient-derived lung airway model to study CFTR function

(414) Longitudinal analysis of early life bronchoalveolar fluid identifies immune mediators associated with bronchiectasis risk in children with CF

(415) Bacteriophages that Treat Pseudomonas aeruginosa Infections Induce Pro-Inflammatory Immune Responses in the CF Airway Epithelium